Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease

The disease-modifying effects of target of rapamycin complex 1 (TORC1) inhibitors during different stages of polycystic kidney disease (PKD) are not well defined. In this study, male Lewis Polycystic Kidney Disease (LPK) rats (a genetic ortholog of human NPHP9, phenotypically characterised by diffus...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Ta, Michelle H. T., Schwensen, Kristina G., Foster, Sheryl, Korgaonkar, Mayuresh, Ozimek-Kulik, Justyna E., Phillips, Jacqueline K., Peduto, Anthony, Rangan, Gopala K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2016
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5056751/
https://ncbi.nlm.nih.gov/pubmed/27723777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0164193
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak